| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2537-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_757405edded2415ef8bb4e2a3c85e315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53433f6f83a627c05f6f5b1ea29d3846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c611d315a35557a22b98d9cc225a0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2a54e1553adbff8689330328d7ec76d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031f83af08fef9a8c09b3a94ccaaa904 |
| publicationDate |
2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021092236-A1 |
| titleOfInvention |
Systems and methods for deconvoluting tumor ecosystems for personalized cancer therapy |
| abstract |
Methods and systems for deconvoluting tumor ecosystems for personalized cancer therapy are disclosed. Generally, human cancers exhibit large variation in behavior between and within patients, which is in large part related to cellular composition. Identifying cell types can identify specific types of tumors and/or cancers present in an individual. Further embodiments generally describe identifying therapies from clinical trials to which the tumor or cancer ecotypes respond, thus providing personalized therapies based on the identified cancer or tumor type. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113593640-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023142041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113593640-A |
| priorityDate |
2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |